B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.685 -0.025 (-0.37%)
Streaming Delayed Price Updated: 10:34 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins. 
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
Via ACCESS Newswire
News headline image
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
Via Chartmill
News headline image
Insights Ahead: Champions Oncology's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Champions Oncology Reports Record Annual Revenue of $57 Million
Via ACCESS Newswire
News headline image
Earnings Scheduled For July 23, 2025 ↗
 
Via Benzinga
News headline image
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Earnings Scheduled For September 15, 2025 ↗
 
Via Benzinga
News headline image
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Via ACCESS Newswire
News headline image
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline. 
Via Benzinga
News headline image
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
Via ACCESS Newswire
News headline image
Recap: Champions Oncology Q2 Earnings ↗
 
Via Benzinga
News headline image
A Peek at Champions Oncology's Future Earnings ↗
 
Via Benzinga
News headline image
Champions Oncology Announces Appointment of New CEO
Via ACCESS Newswire
News headline image
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Via ACCESS Newswire
News headline image
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Via ACCESS Newswire
News headline image
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
Via ACCESS Newswire
News headline image
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
Via ACCESS Newswire
News headline image
Earnings Scheduled For March 11, 2025 ↗
 
Via Benzinga
News headline image
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Via ACCESS Newswire
News headline image
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
Via ACCESS Newswire
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Via ACCESSWIRE
News headline image
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Via ACCESSWIRE
News headline image
Earnings Scheduled For December 11, 2024 ↗
 
Via Benzinga
News headline image
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
Via ACCESSWIRE
News headline image
Champions Oncology Announces Agreement with Weill Cornell Medicine
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.